Patents by Inventor Chad Beyer

Chad Beyer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of Compounds Elevating Glutathione Levels for the Treatment of Autism, Autistic Spectrum Disorders and Fragile X Syndrome
    Publication number: 20150045312
    Abstract: Methods of treating autism, autistic spectrum disorders or Fragile X syndrome comprised of administering molecules that engage the cystine-glutamate exchange (System xc?) and/or elevate the extracellular levels of glutathione in the CNS. Preferred compounds are cysteine/cystine prodrugs or N-acetyl cysteine (NAC) prodrugs.
    Type: Application
    Filed: August 11, 2014
    Publication date: February 12, 2015
    Inventors: Michael Neary, Chad Beyer
  • Use of Compounds Elevating Glutathione Levels for the Treatment of Parkinson's Disease
    Publication number: 20130338165
    Abstract: Methods of treating Parkinson's Disease comprising administering compounds that up-regulate cystine-glutamate exchange (system Xc?) and/or increase glutathione levels in the brain cells. Preferred compounds are cysteine/cystine prodrugs or N-acetyl cysteine (NAC) prodrugs.
    Type: Application
    Filed: June 17, 2013
    Publication date: December 19, 2013
    Inventors: David A. Baker, Daniel G. Lawton, Chad Beyer, Michael Neary
  • Methods for the treatment of anxiety and for identification of anxiolytic agents
    Publication number: 20070111929
    Abstract: Methods for the treatment of neuropsychiatric disorders such as anxiety are disclosed. The methods involve modulating the expression of the angiotensin IV receptor or modulating the biological activity of the angiotensin IV receptor by utilizing antagonists to the receptor. Also disclosed are methods for identifying antagonists of the angiotensin IV receptor that are effective to reduce anxiety in a subject.
    Type: Application
    Filed: August 23, 2006
    Publication date: May 17, 2007
    Applicant: Wyeth
    Inventors: Chad Beyer, Robert Mark
  • Methods of treating vasomotor symptoms
    Publication number: 20050130987
    Abstract: The present invention relates to selective adrenergica2B antagonists alone, selective adrenergic?2B antagonists in combination with norepinephrine reuptake inhibitors (NRI) (as a single compound or as a combination of two or more compounds), or selective adrenergic?2B antagonists in combination with dual norepinephrine reuptake inhibitors/serotonin reuptake inhibitors (NRI/SRI) (as a single compound or as a combination of two or more compounds) and methods of their use in the treatment of vasomotor symptoms.
    Type: Application
    Filed: October 12, 2004
    Publication date: June 16, 2005
    Applicant: Wyeth
    Inventors: Darlene Deecher, Chad Beyer, Liza Leventhal